Implementing pharmacogenomics in europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Presentation
  • By: HOLSAPPEL, Inge (Royal Dutch Pharmacists Association, Medicine Information Centre, Den Haag, Netherlands)
  • Co-author(s): Inge Holsappel: Medicine Information Centre, Royal Dutch Pharmacists Association, Den Haag, Netherlands
    Ka-Chun Cheung: Medicine Information Centre, Royal Dutch Pharmacists Association, Den Haag, Netherlands
    Mandy Crommentuijn-van Rhenen: Medicine Information Centre, Royal Dutch Pharmacists Association, Den Haag, Netherlands
    Henk-Jan Guchelaar: Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands
    Christina Mitropoulou: The Golden Helix Foundation, London, United Kingdom
    Matthias Samwald: Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria
    Matthias Schwab: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany;Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany
    Jesse Swen: Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands
  • Abstract:

    Methods

    On Jan 1st2016 the consortium started with the preparations for the prospective, block-randomized, controlled clinical study (PREPARE). Among other things these preparations included inventarisation of existing guidelines and country-specific information, translation of guidelines in seven languages and selection of genetic variants for

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login